10x Genomics (TXG) Short term Debt (2018 - 2019)
10x Genomics (TXG) posted Short term Debt of $9.9 million for Q4 2019, up 33.85% sequentially from $7.4 million in Q3 2019, and up 136.02% YoY from $4.2 million in Q4 2018.
10x Genomics (TXG) Short term Debt (2018 - 2019) Analysis & Trends
10x Genomics has reported Short term Debt for 2 years, with the latest figure at $9.9 million in Q4 2019.
- Quarterly Short term Debt rose 136.02% year-over-year to $9.9 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $9.9 million (up 136.02% YoY) and the FY2019 annual result came in at $9.9 million, up 136.02% from the prior year.
- Short term Debt climbed to $9.9 million in Q4 2019 per TXG's latest filing, from $7.4 million in the prior quarter.
- Over five years, Short term Debt peaked at $9.9 million in Q4 2019 and troughed at $4.2 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9.88 Mn |
| Sep 30, 2019 | 7.38 Mn |
| Dec 31, 2018 | 4.19 Mn |